abstract |
Reagents that modulate human serine-threonine protein kinase and that bind to the human serine-threonine protein kinase gene product can be functionally impaired, including but not limited to cancer, CNS disorders, diabetes, asthma, and COPD. It can serve to prevent, ameliorate or cure the disease. |